CUHK’s Dennis Lo launches blood tests with Prenetics Group to find cancer cells in the liver and lungs, propelling Hong Kong’s role as R&D hub for life sciences
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
The venture -the largest life sciences transaction in Asia this year – would also spearhead the development of a life science ecosystem in Hong Kong, and help the city’s position as a biotech hub.